April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
Amelioration Of Th1 And Th17 Mediated EAU By IL27p28
Author Affiliations & Notes
  • Wai Po Chong
    Laboratory of Immunology, NEI, Bethesda, Maryland
  • Reiko Horai
    Laboratory of Immunology, NEI, Bethesda, Maryland
  • Phyllis Silver
    Laboratory of Immunology, NEI, Bethesda, Maryland
  • Mary Mattapallil
    Laboratory of Immunology, NEI, Bethesda, Maryland
  • Rachel Caspi
    Laboratory of Immunology, NEI, Bethesda, Maryland
  • Footnotes
    Commercial Relationships  Wai Po Chong, None; Reiko Horai, None; Phyllis Silver, None; Mary Mattapallil, None; Rachel Caspi, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3393. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Wai Po Chong, Reiko Horai, Phyllis Silver, Mary Mattapallil, Rachel Caspi; Amelioration Of Th1 And Th17 Mediated EAU By IL27p28. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3393.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Uveitis involves both Th1 and Th17 immune responses. In animal models, each effector type can mediate experimental autoimmune uveitis (EAU) independently of the other. A method that targets both immune responses would therefoer be an attractive therapeutic approach. The p28 subunit of IL-27, IL27p28, was recently reported to be an antagonist of gp130, which is required for IL-6 and IL-27 signaling. Since IL-6 and IL 27 are important in promoting Th17 and Th1 responses, respectively, we examined the ability of IL27p28 to modulate Th1 and Th17 induced EAU.

Methods: : The open reading frame of mouse IL27p28 was cloned into an expression vector, pCDNA3.1. Th1 or Th17 EAUs were induced in B10.RIII mice by adoptive transfer of Th1 or Th17 polarized IRBP161-180 TCR transgenic T cells. On the day of adoptive transfer, mice received a hydrodynamic injection of the p28 plasmid to induce in vivo IL27p28 expression. The vector without the IL27p28 insert was also injected as a control. Disease severity was monitored by funduscopy.

Results: : After injection of IL27p28 expression plasmid into naïve mice, IL27p28 was detected in the serum for > 7 days after a single hydrodynamic injection of 20 µg plasmid. Adoptive transfer of Th17 cells resulted in an earlier onset of EAU (indidence 66% day 4; 100% day 6) then Th1 cells (incidence 0% day 4; 83% day 6). In Th17 EAU, injection of IL27p28 plasmid decreased disease scores from 1.65±0.29 to 1.1±0.29 (p< 0.05). In Th1 EAU, disease scores were reduced from 1.48±0.51 to 0.63±0.41 (p< 0.05).

Conclusions: : Elevated systemic levels of IL27p28 suppress both Th1 and Th17 EAU by inhibiting the pathogenicity of polarized retina-specific effector T cells. This may suggest the usefulness of IL27p28 augmentation in established disease.

Keywords: uveitis-clinical/animal model • immunomodulation/immunoregulation 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.